IRIX Stock Analysis

IRIDEX Corporation
HEALTHCARE MEDICAL DEVICES

Back to Winners View Yahoo Finance Chart Buy on the Dip
Strong Caution Mixed Weak Unavailable
StockValueFinder Grade
F
33.00 / 100
Weak
Confidence: Moderate (78.0%) Coverage: 78.0%
Business Quality 5.5
Financial Strength 74.1
Earnings & Growth 33.0
Valuation 34.5
Market Strength 22.1
The grade combines Business Quality, Financial Strength, Earnings & Growth, Valuation, and Market Strength. Rating and Trend remain separate signals.
Rating AVOID
Avoid
The screening rules are warning against this setup.
Rating is the simple decision label from the screening rules.
Trend WEAK TREND
Unclear
Trend interpretation is unavailable.
Trend shows whether price action is helping or hurting the setup.
P/E Ratio -2.92
Not Meaningful
Negative or missing earnings make P/E hard to use.
P/E shows how much investors pay for each dollar of earnings.
ROIC -46.93%
Poor
Negative ROIC suggests capital is not being used profitably.
ROIC measures how efficiently capital turns into profit.
Debt Payback -1.65 yrs
Unavailable
Debt payback is unavailable or not meaningful.
Debt payback estimates how quickly debt could be covered.
Price $0.76
Market Price
Price alone is not a buy or sell signal.
Price should be judged with valuation, quality, and trend.
Last updated: 2026-10-23 16:36:17

Performance Overview

Trailing adjusted-close returns as of 2026-07-13. Benchmark is SPY.

YTD Return

IRIX -6.14%
SPY +10.45%

1-Year Return

IRIX +5.94%
SPY +21.46%

3-Year Return

IRIX -48.80%
SPY +72.98%

5-Year Return

IRIX -83.20%
SPY +84.05%

Returns are calculated from adjusted close prices and may differ from broker or research-site totals depending on data source, dividend handling, benchmark choice, and latest available trading date.

Legacy Screening Checks

This page uses cached SQL data from the latest StockValueFinder scan, so it loads fast without hitting Alpha Vantage on every page view.

40%
EPS Strength
FAIL

Looks for positive and improving earnings per share.

ROIC 10%+
FAIL

Looks for strong return on invested capital.

Interest Coverage 6+
FAIL

Checks whether operating income comfortably covers interest expense.

Debt Payback ≤ 3 Years
PASS

Checks whether free cash flow could pay down long-term debt quickly.

P/E 15 or Less
PASS

Checks whether valuation is reasonable under the current rule set.

Moving Average Trend
WEAK TREND

Uses 20-day, 50-day, and 200-day moving averages for entry timing context.

A high StockValueFinder score is a research signal, not a guarantee. Strong companies can still fall during recessions, sector downturns, valuation resets, or company-specific events. Always review the business, risks, SEC filings, valuation, and your personal investment goals before buying.

Cached Technical Data

Moving average values from the latest stored scan.

20-Day MA0.76
50-Day MA0.73
200-Day MA1.06
MA Score2

Latest Published Stock Research

Research generated: October 23, 2026

IRIX Stock Analysis: Why IRIDEX Corporation Scored 40% in Stock Value Finder

Analyzing IRIDEX Corporation (IRIX): An Educational Stock Research Review

Welcome to this detailed stock research review of IRIDEX Corporation (IRIX). This article is presented as an educational guide by StockValueFinder.com to help investors understand how to evaluate a company using a systematic, number-driven approach. Rather than relying on intuition or hype, we use specific financial metrics to determine if a company meets the criteria for quality, safety, and valuation.

IRIDEX Corporation operates within the Healthcare sector, specifically in the Medical Devices industry. For those new to stock analysis, the medical device industry often requires a balance of high research and development spending and the ability to maintain steady margins through regulatory approvals. In this review, we will dissect the current financial standing of IRIX based on the data provided by the StockValueFinder system.

Why the StockValueFinder Score Matters

The StockValueFinder system assigns a percentage score to every ticker to provide a snapshot of how many of our strict financial health and valuation tests a company has passed. For IRIDEX Corporation (IRIX), the current score is 40%, and the resulting rating is AVOID.

A score of 40% indicates that the company failed the majority of the fundamental screens. In a high-quality investment scenario, a researcher typically looks for a significantly higher score, indicating that the company is not only growing but doing so efficiently and safely. When a stock receives an "AVOID" rating, it suggests that the risks identified in the fundamental tests outweigh the potential benefits at the current price of $0.76.

Understanding this score is the first step in educational investing. A low score does not necessarily mean a company will go bankrupt, but it does mean the company does not currently meet the quantitative standards of a "value" or "quality" investment.

EPS Strength and Consistency

Earnings Per Share (EPS) is a critical metric because it tells us how much profit is allocated to each outstanding share of common stock. Consistency in EPS is vital; a company that grows its earnings steadily is generally more predictable and less risky than one with volatile or negative earnings.

For IRIDEX Corporation, the EPS test result is: Did not pass.

While specific historical EPS figures were not supplied in this data set, the system recorded a failure for this test. In a strong scenario, an investor looks for positive EPS that is either growing or stable over a multi-year period. A failure in the EPS test usually occurs when a company is reporting net losses or when earnings are too inconsistent to project future growth.

**Educational Example:** Imagine Company A has an EPS of $1.00, $1.10, and $1.20 over three years. This shows a steady upward trend. Now imagine Company B has an EPS of $1.00, -$0.50, and $0.20. Company B is far riskier because its ability to generate profit is unreliable. IRIX falls into the latter category of inconsistency or lack of profitability.

ROIC and Capital Efficiency

Return on Invested Capital (ROIC) is perhaps the most important metric for determining if a company is actually creating value. ROIC measures how effectively a company uses its money (both debt and equity) to generate profit.

The supplied ROIC for IRIDEX Corporation is -46.93%.

StockValueFinder generally prefers an ROIC of 10% or higher. A positive ROIC indicates that the company is earning more on its investments than the cost of the capital it used to make those investments. A negative ROIC, such as -46.93%, indicates that the company is currently destroying value—meaning the capital invested in the business is resulting in a loss rather than a gain.

**Educational Example:** If a company invests $100 million into a new factory and generates $15 million in annual profit, its ROIC is 15%. This is a healthy use of capital. If another company invests $100 million and loses $4 million, its ROIC is -4%. A company with 15% ROIC is using its capital far more efficiently than one with 4% or negative ROIC. IRIX’s deeply negative ROIC is a significant red flag for capital efficiency.

Interest Coverage and Financial Safety

Interest coverage is a safety metric. It measures a company's ability to pay the interest on its outstanding debt using its operating income. It tells us how much "breathing room" a company has before it cannot meet its debt obligations.

For IRIDEX Corporation, the Interest Coverage test result is: Did not pass.

StockValueFinder prefers an interest coverage ratio of 6 or higher. A ratio of 6 means the company earns six times more than it needs to cover its interest payments. When a company fails this test, it suggests that its earnings are either too low or negative, making it difficult to service debt without relying on outside financing or selling assets.

**Educational Example:** If a company has $60,000 in operating income and $10,000 in annual interest payments, its coverage is 6x. This is considered healthy. If a company has $20,000 in income and $10,000 in interest, its coverage is only 2x. The 2x company is much more vulnerable to a slight dip in revenue, which could lead to a default.

Debt Payback and Balance Sheet Discipline

The debt payback metric estimates how many years it would take for a company to pay off its total debt using its current annual earnings. This is a measure of balance sheet discipline.

The supplied debt payback value for IRIDEX Corporation is -1.65 years.

StockValueFinder prefers a debt payback period of 3 years or less. Generally, a company that can clear its debts in a short window is considered financially stable. However, it is important to note that a negative number in this field usually occurs when the company has negative earnings. If a company is losing money, it cannot "pay back" debt using earnings, regardless of the numerical result. Despite this, the system marked the Debt Payback test as: Passed. This often occurs when the total debt load is very low relative to the company's assets, meaning the company isn't burdened by massive loans even if current earnings are poor.

**Educational Example:** A company with $1 million in debt and $500,000 in annual profit has a payback period of 2 years (Attractive). A company with $1 million in debt and $100,000 in annual profit has a payback period of 10 years (Weak).

P/E Ratio and Valuation Discipline

The Price-to-Earnings (P/E) ratio compares the stock price to the earnings per share. It tells us how much the market is willing to pay for every $1 of profit.

The supplied P/E ratio for IRIDEX Corporation is -2.92.

StockValueFinder prefers a P/E of 15 or lower for valuation discipline. A lower P/E often suggests a stock is undervalued, provided the business is healthy. However, a negative P/E ratio (like -2.92) indicates that the company is not currently profitable. Because the company is not earning money, the traditional P/E valuation is skewed. Despite the negative earnings, the system marked the P/E valuation test as: Passed. This is typically because the stock price ($0.76) is so low that it does not represent an "overpriced" growth bubble.

**Educational Example:** If Company X has a P/E of 8 and Company Y has a P/E of 40, Company X is more value-oriented. You are paying $8 for every $1 of profit, whereas with Company Y, you are paying $40. However, if Company X has a negative P/E, it means there are no profits to value, which shifts the risk profile entirely.

Moving Average Trend and Entry Timing

While fundamental metrics tell us *what* to buy, technical trends help us decide *when* to buy. We use moving averages to identify the momentum of a stock.

The moving average signal for IRIX is: WEAK TREND. The entry signal is: N/A.

A "Weak Trend" indicates that the stock is not currently showing the upward momentum required for a high-probability entry. It is important to remember that trend analysis is used for timing discipline; it is not a guarantee that a stock must rise or fall, but rather a tool to avoid "catching a falling knife."

Regarding entry and risk areas

Limit buy idea: N/A - Pullback zone: N/A - Risk stop / trend risk level: N/A

These fields are provided as educational reference levels to help investors manage risk. Because there is no strong upward trend and the fundamentals are weak, the system has not provided specific entry or stop-loss levels.

Overall Financial Strengths and Weaknesses

To summarize the data for IRIDEX Corporation

**Strengths:** - The company passed the P/E valuation test, suggesting the stock is not overpriced in a traditional growth-bubble sense. - The company passed the debt payback test, suggesting that its total debt burden is not currently an insurmountable obstacle relative to its size.

**Weaknesses:** - Failed the EPS test, indicating a lack of consistent profitability. - Failed the ROIC test with a severe value-destruction rate of -46.93%. - Failed the interest coverage test, indicating a lack of financial safety regarding debt servicing. - The technical trend is categorized as "WEAK," suggesting no immediate positive momentum.

Risks and Limitations

Investing in companies with a 40% StockValueFinder score involves significant risk. The primary risk for IRIX is the combination of negative ROIC and failed interest coverage. When a company loses money on the capital it invests and struggles to cover its interest, it may be forced to issue more shares (diluting current shareholders) or take on more expensive debt to survive.

Furthermore, with a stock price of $0.76, the company is in a volatile price range where small movements can result in large percentage swings. Without a strong entry signal or a positive moving average trend, there is no technical evidence to suggest a reversal in the current trajectory.

Educational Conclusion

Analyzing IRIDEX Corporation (IRIX) provides a textbook example of why multiple metrics must be used together. If an investor looked only at the "Passed" P/E valuation test, they might think the stock is a bargain. However, when that "bargain" is paired with a -46.93% ROIC and a failed interest coverage test, the picture changes. A low price is only a value if the underlying business is efficient and safe.

By applying these screens—EPS consistency, ROIC efficiency, interest coverage safety, debt payback discipline, and P/E valuation—investors can filter out high-risk assets and focus on companies that demonstrate a proven ability to generate wealth.

This article is for research and educational purposes only. It is not personal financial advice, investment advice, or a recommendation to buy or sell any security.


Research links: Yahoo Finance | Seeking Alpha | Finviz | SEC Filings

Research Attribution
Omar Gemani

Specializing in global financial markets, macroeconomic trends, and equity valuation, Omar Gemani brings a disciplined, research-driven perspective to investment analysis. His editorial approach emphasizes company fundamentals, earnings sustainability, financial strength, and long-term growth potential. Combining fundamental analysis with broader economic indicators, Omar evaluates investment opportunities while highlighting market uncertainty, valuation risks, and the importance of capital preservation.

30-Day Trendline Analysis

Optional intraday chart with rising support, falling resistance, and multi-timeframe views.

Load detailed price structure only when needed. Downloads roughly 30 days of 5-minute candles, identifies swing points, then calculates validated support and resistance lines.
Scroll to Top